CalciMedica Inc — Cash Flow (NASDAQ:CALC) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -32.06 M-31.5 M-22.88 M-25.73 M-21.15 M-21.18 M -21.18 M Cash from investing activities -42.56 M10.75 M26.96 M8.88 M-4.42 M9.55 M 9.55 M Cash from financing activities 92.17 M695 K-139 K20.9 M27.97 M15.21 M 15.21 M Free cash flow -33.09 M-31.99 M-23.19 M-25.81 M-21.15 M-21.21 M -21.21 M

Haberler

CalciMedica’ya Nasdaq’tan iki uyarı birden

H.C. Wainwright, klinik deneme durdurmasının ardından CalciMedica hissesini Nötr’e düşürdü

CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt

CalciMedica, Faz 2 KOURAGE denemesini komitenin tavsiyesi üzerine durdurdu

CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.02%

CalciMedica hisseleri böbrek hasarı denemesinin durdurulmasının ardından düşüşte

CalciMedica, güvenlik endişeleri nedeniyle AKI denemesini durdurdu

CalciMedica discontinues AKI trial following safety concerns

CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - CalciMedica (NASDAQ:CALC)

Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial

CalciMedica partners with Telperian to use AI for clinical trial analysis